Stoffel, T.; Bacher, U.; Banz, Y.; Daskalakis, M.; Novak, U.; Pabst, T.
BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL—A Pilot Study. J. Clin. Med. 2022, 11, 3748.
https://doi.org/10.3390/jcm11133748
AMA Style
Stoffel T, Bacher U, Banz Y, Daskalakis M, Novak U, Pabst T.
BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL—A Pilot Study. Journal of Clinical Medicine. 2022; 11(13):3748.
https://doi.org/10.3390/jcm11133748
Chicago/Turabian Style
Stoffel, Tanja, Ulrike Bacher, Yara Banz, Michael Daskalakis, Urban Novak, and Thomas Pabst.
2022. "BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL—A Pilot Study" Journal of Clinical Medicine 11, no. 13: 3748.
https://doi.org/10.3390/jcm11133748
APA Style
Stoffel, T., Bacher, U., Banz, Y., Daskalakis, M., Novak, U., & Pabst, T.
(2022). BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL—A Pilot Study. Journal of Clinical Medicine, 11(13), 3748.
https://doi.org/10.3390/jcm11133748